Events

« All Events

ASGCT 2025

May 13 - May 17

The American Society of Gene and Cell Therapy’s (ASGCT) Annual Meeting is the premier event for gene and cell therapy professionals. The meeting is the best place for people in the field to learn from the latest scientific research, stay current on new technologies, and make career-advancing connections with peers.

Booth #237

Add to calendar

• Google Calendar
• iCalendar
• Outlook 365
• Outlook Live

Details

Start:

May 13

End:

May 17

Event Category:

Conference

Website:

https://annualmeeting.asgct.org/

Venue

Ernest N. Morial Convention Center

New Orleans, LA United States

Related Events

• 

  DCAT Week

  March 17 - March 20
• 

  BPI West

  March 18 - March 21
• 

  ASC BioT – 2025 Annual Conference

  March 23 - March 27

News

• GHO & Ampersand Complete Acquisition of Avid Bioservices

  February 5, 2025

  Download PDF Avid Bioservices poised for significant growth with new partners GHO Capital and Ampersand Capital Partners Acquisition of biologics Contract Development and Manufacturing Organisation Avid Bioservices now completed GHO […]

  Read more

• Avid Bioservices, Inc. Provides Notice of Fundamental Change and Make-Whole Fundamental Change to Holders of its Convertible Notes in Connection with Completed Merger

  February 5, 2025

  Download PDFAvid Bioservices, Inc. Provides Notice of Fundamental Change and Make-Whole Fundamental Change to Holders of its Convertible Notes in Connection with Completed Merger TUSTIN, Calif., February 5, 2025 — Avid […]

  Read more

• Avid Stockholders Approve Transaction with GHO and Ampersand

  January 30, 2025

  Download PDFTUSTIN, Calif., Jan. 30, 2025 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ: CDMO) (“Avid” or the “Company”), a dedicated biologics contract development and manufacturing organization (“CDMO”) working to improve […]

  Read more

• Avid Bioservices to be Acquired by GHO Capital Partners and Ampersand Capital Partners in $1.1 Billion Transaction

  November 6, 2024

  Download PDFTUSTIN, Calif. and LONDON and BOSTON, Nov. 06, 2024 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ: CDMO) (“Avid” or the “Company”), a dedicated biologics contract development and manufacturing organization (“CDMO”) working to improve patient lives by providing […]

  Read more

• Avid Bioservices to Participate in Craig-Hallum Bioprocessing Conference

  September 12, 2024

  Download PDFTUSTIN, Calif., Sept. 12, 2024 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and […]

  Read more

• Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability Performance

  May 23, 2024

  Download PDFTUSTIN, Calif., May 23, 2024 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and […]

  Read more

< View Older News